Neuroservices-Alliance
Private Company
Total funding raised: $2.8M
Overview
Neuroservices-Alliance is a Paris-based, privately-held CRO founded in 2010, focused exclusively on the challenging field of CNS and pain research. It operates as a 'one-stop shop,' providing integrated services from cell-based assays to complex in vivo models, leveraging techniques like patch-clamp, MEA, calcium imaging, and work with human-derived neural organoids. The company's value proposition centers on deep scientific expertise, high-quality reproducible data, and interactive client support throughout the study lifecycle. It serves pharmaceutical and biotech clients, generating revenue through fee-for-service contracts.
Technology Platform
Integrated suite of electrophysiology and neuropharmacology platforms including Cell Electrophysiology (patch-clamp), Human & Rodent Neural Organoids, Ex Vivo Brain Slice recordings, In Vivo Brain Electrophysiology (LFP/EEG/optogenetics), and In Vivo Spinal Cord/DRG recordings, complemented by Calcium Imaging and MEA.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes in the niche of neuroscience-focused CROs. Differentiates through a comprehensive, integrated 'one-stop-shop' approach spanning from cells to in vivo models, with a specific emphasis on high-content electrophysiology and human-derived organoid models. Must compete on scientific expertise, data quality, and client collaboration against both other specialists and broader preclinical CROs.